Skip to main content

Cost-Effectiveness and Cost Utility Analyses: Methods for the Non-Economic Evaluation of Health Care Programmes and How We Can Do Better

  • Chapter

Part of the book series: Management of Medical Technology ((MOMT,volume 1))

Abstract

Health care procedures are not generally provided and consumed as an end in themselves, but as a means of improving the expected health status of those undergoing the procedures. Health technology assessment aims to provide objective information about the impacts of technologies, including safety, effectiveness, outcomes and costs, as well as social and ethical consequences, in order to assist in making health care decisions and setting health policy. Aging populations, changes in the incidence of diseases and the increasing expectations of populations associated with the rapid developments in medical research have all led to increased pressures on health care systems. In response to these pressures an increasing amount of literature has focussed on the economic evaluation of health care programmes over the lastly twenty five years or so. Studies that have appraised the methods adopted in these evaluations have reported a low1,2 and reducing3,4 rate of compliance with the recommended (and published guidelines for economic evaluations5–11 and have led others to comment on the use and misuse of the evaluation terminology.12

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Drummond MF. (1980b) Studies in economic appraisal in health care. Oxford University Press, Oxford.

    Google Scholar 

  2. Drummond MF, Ludbrook A, Lowson K, Steele A. (1986) Studies in economic appraisal in health care. Volume 2, Oxford University Press, Oxford.

    Google Scholar 

  3. Warner KE, Hutton RC. (1980) Cost-benefit and cost-effectiveness analysis in health care: Growth and composition of the literature. Medical Care, 18:1069–1084.

    Article  Google Scholar 

  4. Udvarhelyi S, Colditz GA, Rai A, Epstein AM. (1992) Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Annals of Internal Medicine, 116:238–244.

    Google Scholar 

  5. Weinstein MC, Stason WB. (1977) Foundation of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 296:716–721.

    Article  Google Scholar 

  6. Shepard DS, Thompson MS. (1979) First principles of cost-effectiveness analysis in health. Public Health Reports, 94:535–543.

    Google Scholar 

  7. Sugden R, Williams A. (1978) The principles of practical cost-benefit. Oxford University Press, Oxford.

    Google Scholar 

  8. Drummond MF. (1980) Principles of economic appraisal in health care. Oxford University Press, Oxford.

    Google Scholar 

  9. Warner KE, Luce BR. (1982) Cost-benefit and cost-effectiveness analysis in health care. Health Administration Press, Ann Arbor, Michigan.

    Google Scholar 

  10. Drummond MF, Stoddart GL, Torrance GW. (1987) Methods for the economic evaluation of health care programs. Oxford University Press, Oxford.

    Google Scholar 

  11. Eisenberg JM. (1989) Clinical Economics: A guide to the economic analysis of clinical practices. Journal of American Medical Association, 262:2879–2886.

    Article  Google Scholar 

  12. Doubilet P, Weinstein MC, McNeil BJ. (1986) Use and misuse of the term “cost-effective” in medicine. New England Journal of Medicine, 314:253–256.

    Article  Google Scholar 

  13. Williams A. (1983) The economic role of “health indicators” in G. Teeling Smith (ed.) Measuring the Social Benefits of Medicine. Office of Health Economics, London, 63–67.

    Google Scholar 

  14. Mooney G. (1986) Economics, medicine and health care. Wheatsheaf, Brighton.

    Google Scholar 

  15. Wagstaff A. QALYs and the equity-efficiency trade-off. Journal of Health Economics. 1991;10:21–41.

    Article  Google Scholar 

  16. Green A, Barker C. (1988) Priority setting and economic appraisal: Whose priorities — the community or the economist? Social Science and Medicine, 26:919–929.

    Article  Google Scholar 

  17. Donaldson C. (1990) The state of the art of costing health care for economic evaluation. Community Health Studies, 9:341–356.

    Google Scholar 

  18. Torrance GW. (1986) Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5:1–30.

    Article  Google Scholar 

  19. Feeny D, Torrance GW. (1989) Utility and quality-adjusted life years. International Journal of Technology Assessment in Health Care, 5:559–575.

    Article  Google Scholar 

  20. Donaldson C, Mooney G. (1991) Needs assessment, priority setting, and contracts for health care: an economic view. British Medical Journal, 303:1529–1530.

    Article  Google Scholar 

  21. Donaldson C. (1992) Agenda for health: an economic view. British Medical Journal, 304:770–771.

    Article  Google Scholar 

  22. Laupacis A, Feeny D, Detsky A, Tugwell P. (1992) How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Canadian Medical Association Journal, 146:473–481.

    Google Scholar 

  23. Drummond M. (1987) Resource allocation decisions in health care: A role for quality of life assessments? Journal of Chronic Diseases, 40:605–616.

    Article  Google Scholar 

  24. Culyer A. (1981) Health, economics and health economics in J. VanderGeoz and M. Perlman (eds.) Health, Economics and Health Economics, North Holland, Amsterdam, 3–11.

    Google Scholar 

  25. Birch S, Donaldson C. (1987) Applications of cost-benefit analysis to health care: Departures from welfare economic theory. Journal of Health Economics, 6:211–225.

    Article  Google Scholar 

  26. Gafni A. (1989) The quality of QALYs (quality-adjusted life-years): Do QALYs measure what they at least intend to measure? Health Policy, 13:81–83.

    Article  Google Scholar 

  27. Gafni A, Birch S. (1993) Searching for a common currency: critical appraisal of the scientific basis underlying European harmonization of the measurement of health related quality of life (EuroQol). Health Policy, 1993; 23: 219–228.

    Article  Google Scholar 

  28. Johannesson M, Pliskin J, Weinstein M. Are healthy years equivalent an improvement over Quality-adjusted Life Years? Medical Decision Making. 1993; 13: 281–286.

    Article  Google Scholar 

  29. Culyer A, Wagstaff A. QALYs versus HYEs. Journal of Health Economics. 1993; 12: 311–323.

    Article  Google Scholar 

  30. Mehrez A, Gafni A. Healthy-years Equivalents versus Quality-adjusted Life Years: In pursuit of progress. Medical Decision Making. 1993; 13: 287–292.

    Article  Google Scholar 

  31. Gafni A, Birch S, Mehrez A. Economics, health and health economics: HYEs versus QALYs. Journal of Health Economics. 1993; 12:325–339.

    Article  Google Scholar 

  32. Gafni A, Zylak CJ. Ionic versus nonionic contrast media: a burden or bargain? Canadian Medical Association Journal. 1990; 143: 475–478.

    Google Scholar 

  33. Gafni A. Considerations of the measures useful for quantifying adverse effects of unnecessary hypertension drug therapy. Clinical and Investigative Medicine, 1991; 14:266–270.

    Google Scholar 

  34. Read JL, Quinn RJ, Berwick DM, Finberg HV, Weinstein MC. Preference for health outcomes: comparison of assessment methods. Medical Decision Making. 1984; 4: 315–329.

    Article  Google Scholar 

  35. Hornberger JC, Redelmeier DA, Peterson J. (1992) Variability among methods to assess patients’ well-being and consequent effect on a cost-effectiveness analysis. Journal of Clinical Epidemiology, 45:505–512.

    Article  Google Scholar 

  36. Loomes G, McKenzie L. (1989) The use of QALYs in health care decision making. Social Science and Medicine, 28:299–308.

    Article  Google Scholar 

  37. Culyer A, Lavers R, Williams A. (1971) Social indicators: health, in: Social Trends, No. 2 (Her Majesty’s Stationary Office, London).

    Google Scholar 

  38. Gudex C. (1986) QALYs and their use by the Health Service, Centre for Health Economics Discussion paper no. 20 (University of York).

    Google Scholar 

  39. Williams A. (1983) Applications in management, in G. Teely-Smith (ed.) Measuring Health: A practical approach. John Wiley, New York, 225–244.

    Google Scholar 

  40. Gafni A, Birch S. Equity considerations in utility-based measures of health outcomes in economic appraisals: an adjustment algorithm. Journal of Health Economics, 1991,10:329–342.

    Article  Google Scholar 

  41. Feeny D, Torrance G. (1989) Incorporating utility-based quality-of-life assessment measures in clinical trials. Medical Care, 27:S190–204.

    Article  Google Scholar 

  42. Birch S, Gafni A. (1992) Cost effectiveness/utility analyses: Do current decision rules lead us to where we want to be? Journal of Health Economics, 11:279–296.

    Article  Google Scholar 

  43. Kaplan RM, Bush JW. (1982) Health related quality of life measurement for evaluating research and policy analysis. Health Psychology, 1:61–80.

    Article  Google Scholar 

  44. Weinstein MC. (1986) Challenges for cost-effectiveness research. Medical Decision Making, 6:194–198.

    Article  Google Scholar 

  45. Tubman TR, Halliday HL, Normand C. (1990) Cost of surfactant treatment for severe neonatal respiratory distress syndrome: a randomized controlled trial. British Medical Journal, 301:842–845.

    Article  Google Scholar 

  46. Goel V, Detsky AS. (1989) A cost-utility analysis of preoperative total parenteral nutrition. International Journal of Technology Assessment in Health Care, 5:183–194.

    Article  Google Scholar 

  47. Pickard JD, Bailey S, Sanderson H, Rees M, Garfield JS. (1990) Steps towards cost-benefit analysis of regional neurosurgical care. British Medical Journal, 301:624–635.

    Article  Google Scholar 

  48. Johannesson M, Weinstein M. On the decision rules of cost-effectiveness analysis. Journal of Health Economics (in press).

    Google Scholar 

  49. Weinstein M, Zeckhauser R. Critical rations and efficient allocation. Journal of Public Economics. 1973; 2: 147–157.

    Article  Google Scholar 

  50. Birch S, Gafni A. Changing the problem to fit the solution: Johannesson and Weinstein’s (mis)application of economics to real world problems. Journal of Health Economics (in press).

    Google Scholar 

  51. Gafni A, Birch S. Guidelines for the adoption of new technology: a potential prescription for uncontrolled growth in expenditures and how to avoid it. Canadian Medical Association Journal, 1993; 148:913–917.

    Google Scholar 

  52. Mehrez A, Gafni A. Quality-adjusted life-years, utility theory, and healthy years equivalents. Medical Decision Making, 1989, 9:142–149.

    Article  Google Scholar 

  53. Mehrez A, Gafni A. Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYE). PharmacoEconomics, 1992; 1:338–345.

    Article  Google Scholar 

  54. Mehrez A, Gafni A. (1991) Healthy years equivalent: how to measure them using the standard gamble approach. Medical Decision Making, 11:140–146.

    Article  Google Scholar 

  55. Gafni A. Using willingness-to-pay as a measure of benefits: what is the relevant question to ask in the context of public decision making about health care programs. Medical Care, 1991; 29:1246–1252.

    Article  Google Scholar 

  56. Johannesson M, Johansson PO, Jonsson B. Economic evaluation of drug therapy: a review of the contingent valuation method. Pharmacoeconomics. 1992; 1:325–337.

    Article  Google Scholar 

  57. Mishan EJ. Elements of cost-benefit analysis. London, London, 1972.

    Google Scholar 

  58. Baumol WJ. Economic theory and operations analysis. Englewood Cliffs, NJ. 3rd ed. Prentice Hall, 1972.

    Google Scholar 

  59. Russell LB. Opportunity costs in modern medicine. Health Affairs. 1992; 11:162–169.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Eliezer Geisler Ori Heller

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers

About this chapter

Cite this chapter

Birch, S., Gafni, A. (1996). Cost-Effectiveness and Cost Utility Analyses: Methods for the Non-Economic Evaluation of Health Care Programmes and How We Can Do Better. In: Geisler, E., Heller, O. (eds) Managing Technology in Healthcare. Management of Medical Technology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1415-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1415-8_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8614-1

  • Online ISBN: 978-1-4613-1415-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics